Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

FUE and FUT hair transplants have similar success rates, with FUE slightly better.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Minoxidil response testing helps treat hair loss effectively and safely.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Caucasian hair is denser, but Asian hair is thicker in female pattern hair loss patients.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Break dancing on the head may cause a type of scarring hair loss that needs early treatment to prevent permanent damage.

The herbal hair oil increased hair growth and reduced hair fall for most users without significant side effects.

Enhancing melanin's energy generation may help treat alopecia areata.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

The hedgehog signaling pathway is crucial for hair growth but not for the initial creation of hair follicles.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Somatostatin may help protect hair follicles from immune attacks.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Mice with autoimmune hair loss showed signs of heart problems.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.